White blood cell count predicts infarct size in STEMI

White blood cell count predicts infarct size in STEMI

(HealthDay)—For patients with anterior wall ST-segment elevated myocardial infarction (STEMI), elevated white blood cell count (WBCc) on presentation is associated with increased infarct size, according to a study published in the Dec. 15 issue of The American Journal of Cardiology.

Tullio Palmerini, M.D., from Policlinico S. Orsola in Bologna, Italy, and colleagues examined whether elevated WBCc correlates with increased infarct size measured with cardiac 30 days after primary . Data were from 407 participants with STEMI and proximal or mid-left anterior descending coronary artery occlusion from the Intracoronary Abciximab and Aspiration Thrombectomy in Patients With Large Anterior Myocardial Infarction trial. Participants were stratified according to WBCc tertiles.

The researchers observed an increase in infarct size (percentage of total left ventricular mass) at 30 days across tertiles of increasing WBCcs (median for tertiles I versus II versus III, 11.2 versus 17.5 versus 19.1 percent; P < 0.0001). Across tertiles of WBCc, absolute infarct mass in grams and abnormal wall motion score also increased significantly. WBCc independently predicted infarct size in multivariate analysis, together with intracoronary abciximab randomization, age, time from onset of symptoms to first device, proximal left anterior descending location, and baseline Thrombolysis In Myocardial Infarction flow of 0/1.

"In conclusion, in patients with anterior wall STEMI, an elevated admission WBCc is a powerful independent predictor of infarct size measured with cardiac magnetic resonance imaging 30 days after primary percutaneous coronary intervention," the authors write.

Two authors disclosed financial ties to the medical device industry.

More information: Abstract
Full Text (subscription or payment may be required)

add to favorites email to friend print save as pdf

Related Stories

Results of the CHILL-MI trial presented

Oct 31, 2013

A clinical trial shows that rapidly cooling patients who have suffered ST-elevation myocardial infarction (STEMI, the most serious form of a heart attack) prior to restoring blood flow is safe and feasible. The findings of ...

Results of the TATORT-NSTEMI trial presented

Nov 01, 2013

According to a new study, aspirating blood clots does not significantly reduce microvascular obstruction or reduce the risk of death in patients with non-ST-elevation myocardial infarction (NSTEMI), when compared to standard ...

Recommended for you

Most seniors eligible for statin Rx under new guidelines

Nov 25, 2014

(HealthDay)—Most older Americans qualify for treatment with statins under new guidelines for the treatment of blood cholesterol released late last year by the American College of Cardiology and the American ...

Asymptomatic atherosclerosis linked to cognitive impairment

Nov 25, 2014

In a study of nearly 2,000 adults, researchers found that a buildup of plaque in the body's major arteries was associated with mild cognitive impairment. Results of the study conducted at the University of Texas (UT) Southwestern ...

User comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.